We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REX:NYSEREX American Resources Corporation Analysis

Data as of 2026-04-28 - not real-time

$47.25

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

REX American Resources is trading at $47.25, well above its DCF‑derived fair value of $18.43, suggesting a significant premium. The stock sits above its 20‑day SMA ($44.87) and 50‑day SMA ($40.68) and is approaching the 200‑day SMA ($33.69), confirming a strong bullish bias. Momentum indicators reinforce this view: the RSI is at 69, edging close to overbought territory, while the MACD line (1.41) sits above its signal (1.33) with a positive histogram, signalling continued upward pressure. Technical support sits at $41.38 and resistance near $48.66, leaving limited upside before a potential pull‑back. Volatility is elevated at 43% over the past 30 days, and volume trends are decreasing, which could foreshadow a slowdown in price advances. Fundamentally, the company posted flat revenue growth (-0.2%) and modest margins (gross 14.4%, operating 10.5%, profit 12.8%). Earnings beat expectations with EPS of $2.50, but forward EPS guidance drops to $2.27, indicating decelerating profitability. The balance sheet is strong, with $376 M cash, only $21 M debt, and a debt‑to‑equity ratio of 3.0, yet the price‑to‑earnings multiple of 18.9 and price‑to‑book of 2.55 reflect a valuation that appears stretched relative to intrinsic estimates. No dividend is paid, removing income‑focused appeal. Overall, the stock’s technical vigor is counterbalanced by overvaluation and modest growth prospects, suggesting caution for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical setup (RSI 69, MACD bullish)
  • Proximity to resistance at $48.66
  • Elevated short‑term volatility

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant overvaluation versus DCF fair value
  • Flat revenue growth and declining forward EPS
  • High volatility and decreasing volume trend

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong balance sheet with ample cash and low debt
  • Absence of dividend reduces total return appeal
  • Sector headwinds from regulatory and commodity price dynamics

Key Metrics & Analysis

Financial Health

Revenue Growth-0.20%
Profit Margin12.75%
P/E Ratio18.9
ROE14.13%
ROA5.03%
Debt/Equity3.03
P/B Ratio2.5
Op. Cash Flow$117.8M
Free Cash Flow$18.7M

Technical Analysis

TrendBullish
RSI69.0
Support$41.38
Resistance$48.66
MA 20$44.87
MA 50$40.68
MA 200$33.69
MACDBullish
VolumeDecreasing
Fear & Greed Index89.25

Valuation

Fair Value$18.43
GradeOvervalued
TypeValue

Risk Assessment

Beta0.35
Volatility43.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.